ReviewMolecular biology reports2025
Thyroid peroxidase gene variants and autoimmunity in subclinical hypothyroidism: molecular mechanisms and clinical implications.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subclinical hypothyroidism (SCH), characterized by elevated thyroid-stimulating hormone (TSH) levels with normal thyroid hormone concentrations, is a common endocrine disorder with potential to progress to overt hypothyroidism. Autoimmune thyroiditis particularly Hashimoto's disease is the predominant cause, often marked by the presence of anti-thyroid peroxidase (TPOAbs) antibodies. Thyroid peroxidase (TPO), a key enzyme in thyroid hormone biosynthesis, also serves as a major autoantigen in autoimmune thyroid disorders. This review highlights the dual enzymatic and immunogenic roles of TPO, emphasizing the structural domains critical for both hormone synthesis and antibody binding. Recent evidence links several TPO gene polymorphisms especially in exons 8, 11, and to increased TPOAbs antibody titers and susceptibility to SCH. We further examine the role of gene-environment interactions, including micronutrient deficiencies (vitamin D, B12, iron), iodine status, and demographic factors (age, sex), in modulating immune responses and thyroid function. Exon 8 variants are increasingly recognized as immunogenic hotspots but remain underexplored, particularly in Middle Eastern populations. Understanding these genetic and environmental determinants may improve early diagnosis, enable risk-based screening, and inform personalized prevention strategies. This review advocates for expanded population-specific studies and supports integrating genetic markers with clinical parameters to refine SCH detection and management.
Indexed as
Identifiers
41117839What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.